 | Up a level |
Journal Article
Frost, Nikolaj 
ORCID: 0000-0001-7452-7129, Christopoulos, Petros ORCID: 0000-0002-7966-8980, Kauffmann-Guerrero, Diego, Stratmann, Jan, Riedel, Richard, Schaefer, Monica, Alt, Jurgen, Gutz, Sylvia, Christoph, Daniel C., Laack, Eckart, Faehling, Martin, Fischer, Richard, Fenchel, Klaus, Haen, Sebastian, Heukamp, Lukas, Schulz, Christian and Griesinger, Frank
(2021).
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.
Ther. Adv. Med. Oncol., 13.
LONDON:
SAGE PUBLICATIONS LTD.
ISSN 1758-8359
Mairinger, Fabian D., Walter, Robert F. H., Ting, Saskia ORCID: 0000-0003-1415-7714, Vollbrecht, Claudia ORCID: 0000-0002-0861-001X, Kollmeier, Jens ORCID: 0000-0002-8048-3895, Griff, Sergei, Hager, Thomas, Mairinger, Thomas, Christoph, Daniel C., Theegarten, Dirk, Schmid, Kurt Werner and Wohlschlaeger, Jeremias
(2014).
Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma.
Future Oncol., 10 (6).
S. 995 - 1006.
LONDON:
FUTURE MEDICINE LTD.
ISSN 1744-8301
Mairinger, Fabian D., Walter, Robert F. H., Werner, Robert, Christoph, Daniel C., Ting, Saskia ORCID: 0000-0003-1415-7714, Vollbrecht, Claudia ORCID: 0000-0002-0861-001X, Zarogoulidis, Konstantinos, Huang, Haidong, Li, Qiang, Schmid, Kurt W., Wohlschlaeger, Jeremias and Zarogoulidis, Paul
(2014).
Activation of Angiogenesis Differs Strongly Between Pulmonary Carcinoids and Neuroendocrine Carinomas and Is Crucial for Carcinoid Tumourgenesis.
J. Cancer, 5 (6).
S. 465 - 472.
LAKE HAVEN:
IVYSPRING INT PUBL.
ISSN 1837-9664
Metzenmacher, Martin ORCID: 0000-0001-5395-9010, Rizzo, Filippo, Kambartel, Kato, Panse, Jens, Schaufler, Diana, Scheffler, Matthias ORCID: 0000-0002-9031-1368, Azeh, Ivo, Hoiczyk, Mathias, Turki, Amin T., Atz, Judith, Buchner, Hannes, Hoffmann, Christopher and Christoph, Daniel C.
(2021).
Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma.
Future Oncol., 17 (30).
S. 3965 - 3977.
LONDON:
FUTURE MEDICINE LTD.
ISSN 1744-8301
Stratmann, Jan A., Michels, Sebastian, Hornetz, Sofia, Christoph, Daniel C., Sackmann, Sandra, Spengler, Werner, Bischoff, Helge, Schaefer, Monica, Alt, Juergen, Mueller, Annette, Laack, Eckart, Kimmich, Martin, Griesinger, Frank and Sebastian, Martin (2018). Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer. J. Cancer Res. Clin. Oncol., 144 (12). S. 2457 - 2464. NEW YORK: SPRINGER. ISSN 1432-1335